249 Vascular normalization improves the delivery and efficacy of EGFRvIII-CAR-T cells in mouse glioblastoma
Main Authors: | Dai Fukumura, Rakesh K Jain, Jun Ren, Xinyue Dong, Zohreh Amoozgar, Somin Lee, Meenal Datta, Sylvie Roberge, Mark Duquette |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice
by: Dai Fukumura, et al.
Published: (2023-03-01) -
GZ17-6.02 Inhibits the Growth of EGFRvIII+ Glioblastoma
by: Justin Choi, et al.
Published: (2022-04-01) -
Quantitative analysis of the EGFRvIII mutant receptor signaling networks in Glioblastoma
by: Huang, Hua Ming Paul
Published: (2009) -
Phenotypical Flexibility of the EGFRvIII-Positive Glioblastoma Cell Line and the Multidirectional Influence of TGFβ and EGF on These Cells—EGFRvIII Appears as a Weak Oncogene
by: Aneta Włodarczyk, et al.
Published: (2022-10-01) -
Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma
by: Irene Appolloni, et al.
Published: (2021-08-01)